GLASSIA®

Glassia®

FDA INDICATION: GLASSIA is an alpha-1 proteinase inhibitor (human) indicated for chronic augmentation and maintenance therapy in adults with clinically evident emphysema due to severe hereditary deficiency of alpha-1 antitrypsin deficiency. Package Insert

FORM: Liquid

DISTRIBUTOR: Shire

ROUTE OF ADMINISTRATION: Intravenous

DOSAGE STRENGTH1 gram

DILUENT SIZE: 50 mL

DOSE: 60 mg/kg body weight administered once weekly by intravenous infusion

MIXING DEVICE: N/A

STORAGE: Store at 2–8°C (36–46°F). Do not freeze.

SELF-ADMINISTRATION: Yes, after training

HALF-LIFE: 111 ± 33 hours

OTHER WEBSITES: liquidglassia.com